People · Operator
Named in public records as an officer, director or promoter · active 2016–2018 · Biotechnology, Telecommunications
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vir Biotechnology, Inc. | — | Biotechnology | Series D+ | $348.4M | $1.3B | 2018 |
| Magenta Therapeutics, Inc. | — | Biotechnology | Series C | $116.0M | $2.1B | 2016 |
| ImmusanT, Inc. | — | Biotechnology | Series B | $32.7M | $788.8M | 2017 |
| Critical Telephone Applications, Inc | — | Telecommunications | Pre-Seed | $100K | $2.7M | 2017 |
Thomas Daniel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Daniel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Robert Nelsen | 1 | 22 |
| Kristina Burow | 1 | 16 |
| Bruce Booth | 1 | 12 |
| Robert More | 1 | 7 |
| John Davis | 1 | 7 |
| Vicki Sato | 1 | 6 |
| Alexis Borisy | 1 | 6 |
| JASON GARDNER | 1 | 5 |
| Blake Byers | 1 | 5 |
| George Scangos | 1 | 4 |
| Saira Ramasastry | 1 | 4 |
| Mitesh Patel | 1 | 3 |
| Dipchand Nishar | 1 | 3 |
| Jeffrey Albers | 1 | 3 |
| Robert Perez | 1 | 3 |
| Sundar Kodiyalam | 1 | 2 |
| Thomas Koestler | 1 | 2 |
| Philip Sharp | 1 | 2 |
| Kevin Ferro | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.